We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$510M
Cap. Flow
-$2.26B
Cap. Flow %
-9.9%
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$207M
2
ANSS
Ansys
ANSS
+$201M
3
WWD icon
Woodward
WWD
+$192M
4
SWN
Southwestern Energy Company
SWN
+$168M
5
SQSP
Squarespace, Inc.
SQSP
+$130M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$294M
2
NDAQ icon
Nasdaq
NDAQ
+$256M
3
CRM icon
Salesforce
CRM
+$231M
4
AZN icon
AstraZeneca
AZN
+$188M
5
ARMK icon
Aramark
ARMK
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 31.84%
2 Technology 13.48%
3 Financials 9.84%
4 Communication Services 6.79%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEEV icon
176
Veeva Systems
VEEV
$37.4B
– –
-3,622
Closed -$663K
LUNRW
177
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
– –
-440,965
Closed -$299K
BACA
178
DELISTED
Berenson Acquisition Corp. I
BACA
– –
-285,715
Closed -$3.04M
NUVOW
179
DELISTED
Holdco Nuvo Group D.G Ltd. Warrants
NUVOW
– –
-200,000
Closed -$4.26K
SLAMW
180
DELISTED
Slam Corp. warrant
SLAMW
– –
-17,627
Closed -$4.39K
CVIIW
181
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
– –
-200,000
Closed -$70K
CERE
182
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-1,190,000
Closed -$48.7M
ARYD
183
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-200,000
Closed -$2.29M
SEPAW
184
DELISTED
SEP Acquisition Corp Warrants
SEPAW
– –
-866,250
Closed -$6.41K
KCGI.WS
185
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
– –
-581,400
Closed -$15.1K
4 5 6 7
8

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Farallon Capital Management held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Woodward worth $198M.

  • Farallon Capital Management's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
  • Farallon Capital Management added most to Walt Disney in Q3 2024, an estimated $207M increase.
  • Farallon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
  • Farallon Capital Management fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
  • Farallon Capital Management opened 21 new positions and closed 22 in Q3 2024.
  • Farallon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.